查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1665918

全球醫療美容產品市場：依產品（肉毒桿菌、真皮填充劑）、應用、性別、最終用戶和地區的預測（至2032年）

Global Medical Aesthetic Products Market Research Report Information by Product (Botulinum Toxin, Dermal Fillers), by Application, by Gender, by End User, by Region Forecast Till 2032
出版日期: | 出版商: Market Research Future | 英文 184 Pages | 訂單完成後即時交付

價格

全球醫療美容產品市場規模預計將從2023年的8,971,270,000 美元和2024年的9,702,340,000 美元成長到2032年的22,032,400,000 美元，預測成長率內的年複合成長率為 10.8%。

隨著肉毒桿菌和真皮填充劑的日益普及和接受，以及微創美容手術的日益普及，醫療美容產品市場的發展受到推動。

隨著微創美容手術的普及，醫療美容產品市場大幅擴張。肉毒桿菌和真皮填充劑在消費者中越來越受歡迎，他們尋求有效的解決方案來改善外貌，而無需經歷手術通常所需的漫長恢復期。這些治療方法起效快，而且幾乎不會引起不適，因此吸引了廣泛的人群，包括尋求預防性治療的年輕人。這些微創選擇的便利性和安全性，加上技術和配方的進步，使其非常有吸引力。預計市場的整體擴張將受到透過社交媒體和有影響力的代言不斷提高的對美容益處的認識的推動，這預計將促進對這些美容干預的需求。

區域展望

預計北美的市場佔有率在2023年將達到最高，到2032年將達到 85.9484億美元。另一方面，預計亞太地區在預測期內的年複合成長率最高，為 12.46%。預計到2023年歐洲醫療美容產品市場規模將達到 25.4523億美元，預測期內年複合成長率為 11.62%。

本報告調查了全球醫療美容產品市場，並總結了市場定義和概況、影響市場成長的各種因素的分析、市場規模的趨勢和預測、各區分、地區/主要國家的明細、競爭環境以及主要公司的概況。

目錄

第1章 執行摘要

第2章 市場概覽

第3章 研究方法

第4章 市場動態

  • 促進因素
    • 微創美容手術越來越受歡迎
    • 越來越多的真皮填充劑和肉毒桿菌毒素獲得批准和上市
  • 抑制因素
    • 與皮膚填充劑和肉毒桿菌相關的副作用
    • FDA 關於皮膚填充劑的警告信
    • 肉毒桿菌填充劑假貨和仿製品
  • 機會
    • 老年人口增加

第5章 市場因素分析

  • 波特五力分析
  • COVID-19 對醫美產品市場的影響
  • 消費者偏好
  • 法規狀態
  • 市場趨勢
  • 價格分析
  • 貿易商和經銷商名單：依地區/國家
  • 製造商列表
  • 區域級治療分析

第6章 醫療美容產品市場（依產品）

  • 概述
  • 肉毒桿菌（Botox）
    • A 型
    • B 型
  • 皮膚填充劑
    • 玻尿酸
    • 羥基磷灰石鈣
    • 聚-L-乳酸
    • 聚甲基丙烯酸甲酯微球（PMMA）
    • 聚烷基醯亞胺
    • 其他

第7章 醫療美容產品市場（依應用）

  • 概述
  • 脫毛
  • 皮膚重塑
  • 臉部年輕化
  • 抽脂手術
  • 整容
  • 皮膚移植
  • 減少皺紋
  • 其他

第8章 醫療美容產品市場（依性別）

  • 概述
  • 男性
  • 女性

第9章 醫療美容產品市場（依最終用戶）

  • 概述
  • 醫院及皮膚科診所
  • 醫療水療
  • 美容診所

第10章 醫療美容產品市場（依地區）

  • 概述
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 紐西蘭
    • 其他
  • 其他地區
    • 中東
    • 非洲
    • 拉丁美洲

第11章 競爭格局

  • 市場佔有率分析：真皮填充劑
  • 市場佔有率分析：肉毒桿菌（Botox）
  • 競爭資訊中心
  • 上市公司股票概況
  • 比較分析：主要公司的財務狀況
  • 主要發展與成長策略

第12章 公司簡介

  • REVANCE THERAPEUTICS
  • ABBVIE, INC.
  • SUNEVA MEDICAL
  • BIOXIS PHARMACEUTICALS
  • MERZ PHARMA
  • GALDERMA
  • SINCLAIR
  • MEDYTOX
  • TEOXANE
  • DR. KORMAN

第13章 引用資料

Product Code: MRFR/HC/41750-CR

Global Medical Aesthetic Products Market Research Report Information by Product (Botulinum Toxin (Botox), Dermal Fillers), by Application (Hair Removal, Skin Resurfacing, Facial Rejuvenation, Liposuction, Facelifts, Skin Grafting, Wrinkle Reduction, Others), by Gender (Male, Female), by End User (Hospitals & Dermatological Clinics, Medical Spas, Beauty Clinics), by Region (North America, Europe, Asia-Pacific, Rest of the World) Forecast Till 2032

Market Overview

The market size of medical aesthetic products was estimated to be USD 8,971.27 million in 2023. It is anticipated that the Global Medical Aesthetic Products industry will expand at a compound annual growth rate (CAGR) of 10.8% from USD 9,702.34 Million in 2024 to USD 22,032.40 Million by 2032. This expansion is anticipated to transpire during the forecast period of 2024 to 2032.

The Medical Aesthetic Products Market is being stimulated by the increasing acceptance and introduction of botox and dermal fillers, as well as the increasing popularity of minimally invasive cosmetic procedures.

The Medical Aesthetic Products Market is expanding significantly due to the increasing prevalence of minimally invasive cosmetic procedures. Botox and dermal fillers have gained popularity among consumers who are seeking effective solutions to enhance their appearance without the protracted recovery period typically associated with surgical options. The immediate results and minimal discomfort of these procedures make them appealing to a diverse spectrum of individuals, including younger individuals who are pursuing preventative treatments. The convenience and safety profile of these minimally invasive options, in conjunction with advancements in techniques and formulations, have made them highly appealing. The overall expansion of the market is anticipated to be driven by the ongoing increase in awareness of the benefits through social media and influencer endorsements, which is expected to contribute to the demand for these cosmetic interventions.

Market segment insights

Based on product, the Medical Aesthetic Products Market has been divided into botulinum toxin (Botox) and dermal fillers. A further division of botulinum toxin (Botox) is Type A and Type B. Dermal fillers are further classified as hyaluronic acid, calcium hydroxylapatite, poly-l-lactic acid, polymethyl-methacrylate microspheres (PMMA), and polyalkylimide.

The Market has been categorized into the following categories based on application: hair removal, skin resurfacing, facial rejuvenation, liposuction, facelifts, skin grafting, wrinkle reduction, and others.

The Medical Aesthetic Products Market has been divided into male and female segments according to gender.

The market has been divided into three categories based on the end user: hospitals and dermatological clinics, medical retreats, and cosmetic clinics.

Regional Perspectives

According to region, the Medical Aesthetic Products Market has been divided into North America, Europe, Asia-Pacific, and the Rest of the World. North America's market share was the highest in 2023 and is anticipated to reach USD 8,594.84 million by 2032. Nevertheless, it is anticipated that the Asia-Pacific region will experience the most substantial compound annual growth rate (CAGR) of 12.46% during the forecast period. The Europe Medical Aesthetic Products Market was valued at USD 2,545.23 million in 2023 and is expected to experience a compound annual growth rate (CAGR) of 11.62% during the forecast period. The additional segments of Europe include the United Kingdom, Italy, France, Spain, and Germany. The Asia-Pacific Medical Aesthetic Products Market was valued at USD 1,631.78 million in 2023 and is expected to experience a compound annual growth rate (CAGR) of 12.46% during the forecast period. Subregions of the Asia-Pacific region include China, India, Japan, South Korea, Australia, New Zealand, and the Rest of Asia-Pacific.

Major Players

The Medical Aesthetic Products Market is primarily participated in by Suneva Medical, Abbvie, Inc., Bioxis Pharmaceuticals, Merz Pharma, Galderma, Sinclair, Medytox, Teoxane, and Dr. Korman.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

  • 3.1 OVERVIEW
  • 3.2 DATA FLOW
    • 3.2.1 DATA MINING PROCESS
  • 3.3 PURCHASED DATABASE:
  • 3.4 SECONDARY SOURCES:
    • 3.4.1 SECONDARY RESEARCH DATA FLOW:
  • 3.5 PRIMARY RESEARCH:
    • 3.5.1 PRIMARY RESEARCH DATA FLOW:
  • 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
    • 3.6.1 REVENUE ANALYSIS APPROACH
  • 3.7 DATA FORECASTING
    • 3.7.1 DATA FORECASTING TYPE
  • 3.8 DATA MODELING
    • 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
    • 3.8.2 DATA MODELING:
  • 3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

  • 4.1 INTRODUCTION
  • 4.2 DRIVERS
    • 4.2.1 INCREASING POPULARITY OF MINIMALLY INVASIVE COSMETIC PROCEDURES
    • 4.2.2 RISING APPROVAL AND LAUNCH FOR DERMAL FILLERS AND BOTOX
  • 4.3 RESTRAINTS
    • 4.3.1 SIDE EFFECTS ASSOCIATED WITH DERMAL FILLERS AND BOTOX
    • 4.3.2 FOOD AND DRUG ADMINISTRATION (FDA) WARNING LETTER ASSOCIATED WITH THE DERMAL FILLERS
    • 4.3.3 FAKE AND COUNTERFEIT VERSION OF BOTOX FILLERS
  • 4.4 OPPORTUNITY
    • 4.4.1 GROWING GERIATRIC POPULATION

5 MARKET FACTOR ANALYSIS

  • 5.1 PORTER'S FIVE FORCES MODEL
    • 5.1.1 THREAT OF NEW ENTRANTS
    • 5.1.2 BARGAINING POWER OF SUPPLIERS
    • 5.1.3 THREAT OF SUBSTITUTES
    • 5.1.4 BARGAINING POWER OF BUYERS
    • 5.1.5 INTENSITY OF RIVALRY
  • 5.2 IMPACT OF COVID-19 ON MEDICAL AESTHETIC PRODUCTS MARKET
  • 5.3 CONSUMER PREFERENCE
  • 5.4 REGULATORY LANDSCAPE
    • 5.4.1 NORTH AMERICA
    • 5.4.2 EUROPE
    • 5.4.3 ASIA-PACIFIC
    • 5.4.4 MIDDLE EAST & AFRICA
  • 5.5 MARKET TRENDS IN THE MEDICAL AESTHETIC PRODUCTS MARKET
  • 5.6 PRICING ANALYSIS
  • 5.7 LIST OF TRADERS AND DISTRIBUTORS REGION/COUNTRY
  • 5.8 LIST OF MANUFACTURERS
  • 5.9 PROCEDURE ANALYSIS ON REGIONAL LEVEL (2019-2023)

6 MEDICAL AESTHETIC PRODUCTS MARKET, BY PRODUCT

  • 6.1 OVERVIEW
  • 6.2 BOTULINUM TOXIN (BOTOX)
    • 6.2.1 TYPE A
    • 6.2.2 TYPE B
  • 6.3 DERMAL FILLERS
    • 6.3.1 HYALURONIC ACID
    • 6.3.2 CALCIUM HYDROXYLAPATITE
    • 6.3.3 POLY-L-LACTIC ACID
    • 6.3.4 POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA)
    • 6.3.5 POLYALKYLIMIDE
    • 6.3.6 OTHERS

7 MEDICAL AESTHETIC PRODUCTS MARKET, BY APPLICATION

  • 7.1 OVERVIEW
  • 7.2 HAIR REMOVAL
  • 7.3 SKIN RESURFACING
  • 7.4 FACIAL REJUVENATION
  • 7.5 LIPOSUCTION
  • 7.6 FACELIFTS
  • 7.7 SKIN GRAFTING
  • 7.8 WRINKLE REDUCTION
  • 7.9 OTHERS

8 MEDICAL AESTHETIC PRODUCTS MARKET, BY GENDER

  • 8.1 OVERVIEW
  • 8.2 MALE
  • 8.3 FEMALE

9 MEDICAL AESTHETIC PRODUCTS MARKET, BY END USER

  • 9.1 OVERVIEW
  • 9.2 HOSPITALS & DERMATOLOGICAL CLINICS
  • 9.3 MEDICAL SPAS
  • 9.4 BEAUTY CLINICS

10 MEDICAL AESTHETIC PRODUCTS MARKET, BY REGION

  • 10.1 OVERVIEW
  • 10.2 NORTH AMERICA
    • 10.2.1 US
    • 10.2.2 CANADA
  • 10.3 EUROPE
    • 10.3.1 GERMANY
    • 10.3.2 FRANCE
    • 10.3.3 UK
    • 10.3.4 ITALY
    • 10.3.5 SPAIN
    • 10.3.6 REST OF EUROPE
  • 10.4 ASIA PACIFIC
    • 10.4.1 CHINA
    • 10.4.2 INDIA
    • 10.4.3 JAPAN
    • 10.4.4 SOUTH KOREA
    • 10.4.5 AUSTRALIA
    • 10.4.6 NEW ZEALAND
    • 10.4.7 REST OF ASIA PACIFIC
  • 10.5 REST OF THE WORLD
    • 10.5.1 MIDDLE EAST
    • 10.5.2 AFRICA
    • 10.5.3 LATIN AMERICA
      • 10.5.3.1 ARGENTINA
      • 10.5.3.2 BRAZIL
      • 10.5.3.3 COLOMBIA
      • 10.5.3.4 REST OF LATIN AMERICA

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 MARKET SHARE ANALYSIS, DERMAL FILLERS,
  • 11.3 MARKET SHARE ANALYSIS, BOTULINUM TOXIN (BOTOX),
  • 11.4 COMPETITOR DASHBOARD
  • 11.5 PUBLIC PLAYERS STOCK SUMMARY
  • 11.6 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
  • 11.1 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 11.1.1 PRODUCT LAUNCH
    • 11.1.2 PRODUCT APPROVAL
    • 11.1.3 AGREEMENT
    • 11.1.4 EXPANSION

12 COMPANY PROFILES

  • 12.1 REVANCE THERAPEUTICS
    • 12.1.1 COMPANY OVERVIEW
    • 12.1.2 FINANCIAL OVERVIEW
    • 12.1.3 PRODUCTS OFFERED
    • 12.1.4 KEY DEVELOPMENTS
    • 12.1.5 SWOT ANALYSIS
    • 12.1.6 KEY STRATEGIES
  • 12.2 ABBVIE, INC.
    • 12.2.1 COMPANY OVERVIEW
    • 12.2.2 FINANCIAL OVERVIEW
    • 12.2.3 PRODUCTS OFFERED
    • 12.2.4 KEY DEVELOPMENTS
    • 12.2.5 SWOT ANALYSIS
    • 12.2.6 KEY STRATEGIES
  • 12.3 SUNEVA MEDICAL
    • 12.3.1 COMPANY OVERVIEW
    • 12.3.2 FINANCIAL OVERVIEW
    • 12.3.3 PRODUCTS OFFERED
    • 12.3.4 KEY DEVELOPMENTS
    • 12.3.5 SWOT ANALYSIS
    • 12.3.6 KEY STRATEGIES
  • 12.4 BIOXIS PHARMACEUTICALS
    • 12.4.1 COMPANY OVERVIEW
    • 12.4.2 FINANCIAL OVERVIEW
    • 12.4.3 PRODUCTS OFFERED
    • 12.4.4 KEY DEVELOPMENTS
    • 12.4.5 KEY STRATEGIES
  • 12.5 MERZ PHARMA
    • 12.5.1 COMPANY OVERVIEW
    • 12.5.2 FINANCIAL OVERVIEW
    • 12.5.3 PRODUCTS OFFERED
    • 12.5.4 KEY DEVELOPMENTS
    • 12.5.5 KEY STRATEGIES
  • 12.6 GALDERMA
    • 12.6.1 COMPANY OVERVIEW
    • 12.6.2 FINANCIAL OVERVIEW
    • 12.6.3 PRODUCTS OFFERED
    • 12.6.4 KEY DEVELOPMENTS
    • 12.6.5 SWOT ANALYSIS
    • 12.6.6 KEY STRATEGIES
  • 12.7 SINCLAIR
    • 12.7.1 COMPANY OVERVIEW
    • 12.7.2 FINANCIAL OVERVIEW
    • 12.7.3 PRODUCTS OFFERED
    • 12.7.4 KEY DEVELOPMENTS
    • 12.7.5 SWOT ANALYSIS
    • 12.7.6 KEY STRATEGIES
  • 12.8 MEDYTOX
    • 12.8.1 COMPANY OVERVIEW
    • 12.8.2 FINANCIAL OVERVIEW
    • 12.8.3 PRODUCTS OFFERED
    • 12.8.4 KEY DEVELOPMENTS
    • 12.8.5 KEY STRATEGIES
  • 12.9 TEOXANE
    • 12.9.1 COMPANY OVERVIEW
    • 12.9.2 FINANCIAL OVERVIEW
    • 12.9.3 PRODUCTS OFFERED
    • 12.9.4 KEY DEVELOPMENTS
    • 12.9.5 KEY STRATEGIES
  • 12.10 DR. KORMAN
    • 12.10.1 COMPANY OVERVIEW
    • 12.10.2 FINANCIAL OVERVIEW
    • 12.10.3 PRODUCTS OFFERED
    • 12.10.4 KEY DEVELOPMENTS
    • 12.10.5 KEY STRATEGIES

13 DATA CITATIONS

LIST OF TABLES

  • TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
  • TABLE 2 DERMAL FILLERS AVERAGE PRICING ANALYSIS, BY REGION,
  • TABLE 3 BOTOX AVERAGE PRICING ANALYSIS, BY REGION,
  • TABLE 4 LIST OF TRADERS AND DISTRIBUTORS REGION/COUNTRY
  • TABLE 5 LIST OF MANUFACTURERS
  • TABLE 6 PROCEDURE ANALYSIS ON REGIONAL LEVEL (2019-2023)
  • TABLE 7 MEDICAL AESTHETIC PRODUCTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 8 MEDICAL AESTHETIC PRODUCTS MARKET, FOR BOTULINUM TOXIN (BOTOX), BY REGION, 2019-2032 (USD MILLION)
  • TABLE 9 MEDICAL AESTHETIC PRODUCTS MARKET, FOR BOTULINUM TOXIN (BOTOX), BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 10 MEDICAL AESTHETIC PRODUCTS MARKET, FOR TYPE A, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 11 MEDICAL AESTHETIC PRODUCTS MARKET, FOR TYPE B, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 12 MEDICAL AESTHETIC PRODUCTS MARKET, FOR DERMAL FILLERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 13 MEDICAL AESTHETIC PRODUCTS MARKET, FOR DERMAL FILLERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 14 MEDICAL AESTHETIC PRODUCTS MARKET, FOR HYALURONIC ACID, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 15 MEDICAL AESTHETIC PRODUCTS MARKET, FOR CALCIUM HYDROXYLAPATITE, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 16 MEDICAL AESTHETIC PRODUCTS MARKET, FOR POLY-L-LACTIC ACID, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 17 MEDICAL AESTHETIC PRODUCTS MARKET, FOR POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA), BY REGION, 2019-2032 (USD MILLION)
  • TABLE 18 MEDICAL AESTHETIC PRODUCTS MARKET, FOR POLYALKYLIMIDE, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 19 MEDICAL AESTHETIC PRODUCTS MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 20 MEDICAL AESTHETIC PRODUCTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 21 MEDICAL AESTHETIC PRODUCTS MARKET, FOR HAIR REMOVAL, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 22 MEDICAL AESTHETIC PRODUCTS MARKET, FOR SKIN RESURFACING, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 23 MEDICAL AESTHETIC PRODUCTS MARKET, FOR FACIAL REJUVENATION, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 24 MEDICAL AESTHETIC PRODUCTS MARKET, FOR LIPOSUCTION, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 25 MEDICAL AESTHETIC PRODUCTS MARKET, FOR FACELIFTS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 26 MEDICAL AESTHETIC PRODUCTS MARKET, FOR SKIN GRAFTING, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 27 MEDICAL AESTHETIC PRODUCTS MARKET, FOR WRINKLE REDUCTION, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 28 MEDICAL AESTHETIC PRODUCTS MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 29 MEDICAL AESTHETIC PRODUCTS MARKET, BY GENDER, 2019-2032 (USD MILLION)
  • TABLE 30 MEDICAL AESTHETIC PRODUCTS MARKET, FOR MALE, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 31 MEDICAL AESTHETIC PRODUCTS MARKET, FOR FEMALE, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 32 MEDICAL AESTHETIC PRODUCTS MARKET, BY GENDER, 2019-2032 (USD MILLION)
  • TABLE 33 MEDICAL AESTHETIC PRODUCTS MARKET, FOR HOSPITALS & DERMATOLOGICAL CLINICS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 34 MEDICAL AESTHETIC PRODUCTS MARKET, FOR MEDICAL SPAS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 35 MEDICAL AESTHETIC PRODUCTS MARKET, FOR BEAUTY CLINICS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 36 MEDICAL AESTHETIC PRODUCTS MARKET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37 NORTH AMERICA MEDICAL AESTHETIC PRODUCTS MARKET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38 NORTH AMERICA: MEDICAL AESTHETIC PRODUCTS MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 39 NORTH AMERICA: MEDICAL AESTHETIC PRODUCTS MARKET, FOR BOTULINUM TOXIN (BOTOX), BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 40 NORTH AMERICA: MEDICAL AESTHETIC PRODUCTS MARKET, FOR DERMAL FILLERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 41 NORTH AMERICA: MEDICAL AESTHETIC PRODUCTS MARKET, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 42 NORTH AMERICA: MEDICAL AESTHETIC PRODUCTS MARKET, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 43 NORTH AMERICA: MEDICAL AESTHETIC PRODUCTS MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 44 US: MEDICAL AESTHETIC PRODUCTS MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 45 US: MEDICAL AESTHETIC PRODUCTS MARKET, FOR BOTULINUM TOXIN (BOTOX), BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 46 US: MEDICAL AESTHETIC PRODUCTS MARKET, FOR DERMAL FILLERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 47 US: MEDICAL AESTHETIC PRODUCTS MARKET, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 48 US: MEDICAL AESTHETIC PRODUCTS MARKET, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 49 US: MEDICAL AESTHETIC PRODUCTS MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 50 CANADA: MEDICAL AESTHETIC PRODUCTS MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 51 CANADA: MEDICAL AESTHETIC PRODUCTS MARKET, FOR BOTULINUM TOXIN (BOTOX), BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 52 CANADA: MEDICAL AESTHETIC PRODUCTS MARKET, FOR DERMAL FILLERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 53 CANADA: MEDICAL AESTHETIC PRODUCTS MARKET, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 54 CANADA: MEDICAL AESTHETIC PRODUCTS MARKET, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 55 CANADA: MEDICAL AESTHETIC PRODUCTS MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 56 EUROPE MEDICAL AESTHETIC PRODUCTS MARKET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57 EUROPE: MEDICAL AESTHETIC PRODUCTS MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 58 EUROPE: MEDICAL AESTHETIC PRODUCTS MARKET, FOR BOTULINUM TOXIN (BOTOX), BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 59 EUROPE: MEDICAL AESTHETIC PRODUCTS MARKET, FOR DERMAL FILLERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 60 EUROPE: MEDICAL AESTHETIC PRODUCTS MARKET, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 61 EUROPE: MEDICAL AESTHETIC PRODUCTS MARKET, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 62 EUROPE: MEDICAL AESTHETIC PRODUCTS MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 63 GERMANY: MEDICAL AESTHETIC PRODUCTS MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 64 GERMANY: MEDICAL AESTHETIC PRODUCTS MARKET, FOR BOTULINUM TOXIN (BOTOX), BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 65 GERMANY: MEDICAL AESTHETIC PRODUCTS MARKET, FOR DERMAL FILLERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 66 GERMANY: MEDICAL AESTHETIC PRODUCTS MARKET, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 67 GERMANY: MEDICAL AESTHETIC PRODUCTS MARKET, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 68 GERMANY: MEDICAL AESTHETIC PRODUCTS MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69 FRANCE: MEDICAL AESTHETIC PRODUCTS MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 70 FRANCE: MEDICAL AESTHETIC PRODUCTS MARKET, FOR BOTULINUM TOXIN (BOTOX), BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 71 FRANCE: MEDICAL AESTHETIC PRODUCTS MARKET, FOR DERMAL FILLERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 72 FRANCE: MEDICAL AESTHETIC PRODUCTS MARKET, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73 FRANCE: MEDICAL AESTHETIC PRODUCTS MARKET, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 74 FRANCE: MEDICAL AESTHETIC PRODUCTS MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75 UK: MEDICAL AESTHETIC PRODUCTS MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 76 UK: MEDICAL AESTHETIC PRODUCTS MARKET, FOR BOTULINUM TOXIN (BOTOX), BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 77 UK: MEDICAL AESTHETIC PRODUCTS MARKET, FOR DERMAL FILLERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 78 UK: MEDICAL AESTHETIC PRODUCTS MARKET, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79 UK: MEDICAL AESTHETIC PRODUCTS MARKET, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 80 UK: MEDICAL AESTHETIC PRODUCTS MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81 ITALY: MEDICAL AESTHETIC PRODUCTS MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 82 ITALY: MEDICAL AESTHETIC PRODUCTS MARKET, FOR BOTULINUM TOXIN (BOTOX), BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 83 ITALY: MEDICAL AESTHETIC PRODUCTS MARKET, FOR DERMAL FILLERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 84 ITALY: MEDICAL AESTHETIC PRODUCTS MARKET, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85 ITALY: MEDICAL AESTHETIC PRODUCTS MARKET, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 86 ITALY: MEDICAL AESTHETIC PRODUCTS MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87 SPAIN: MEDICAL AESTHETIC PRODUCTS MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 88 SPAIN: MEDICAL AESTHETIC PRODUCTS MARKET, FOR BOTULINUM TOXIN (BOTOX), BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 89 SPAIN: MEDICAL AESTHETIC PRODUCTS MARKET, FOR DERMAL FILLERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 90 SPAIN: MEDICAL AESTHETIC PRODUCTS MARKET, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91 SPAIN: MEDICAL AESTHETIC PRODUCTS MARKET, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 92 SPAIN: MEDICAL AESTHETIC PRODUCTS MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93 REST OF EUROPE: MEDICAL AESTHETIC PRODUCTS MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 94 REST OF EUROPE: MEDICAL AESTHETIC PRODUCTS MARKET, FOR BOTULINUM TOXIN (BOTOX), BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 95 REST OF EUROPE: MEDICAL AESTHETIC PRODUCTS MARKET, FOR DERMAL FILLERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 96 REST OF EUROPE: MEDICAL AESTHETIC PRODUCTS MARKET, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97 REST OF EUROPE: MEDICAL AESTHETIC PRODUCTS MARKET, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 98 REST OF EUROPE: MEDICAL AESTHETIC PRODUCTS MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99 ASIA PACIFIC MEDICAL AESTHETIC PRODUCTS MARKET, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 100 ASIA PACIFIC: MEDICAL AESTHETIC PRODUCTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 101 ASIA PACIFIC: MEDICAL AESTHETIC PRODUCTS MARKET, FOR BOTULINUM TOXIN (BOTOX), BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 102 ASIA PACIFIC: MEDICAL AESTHETIC PRODUCTS MARKET, FOR DERMAL FILLERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 103 ASIA PACIFIC: MEDICAL AESTHETIC PRODUCTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 104 ASIA PACIFIC: MEDICAL AESTHETIC PRODUCTS MARKET, BY GENDER, 2019-2032 (USD MILLION)
  • TABLE 105 ASIA PACIFIC: MEDICAL AESTHETIC PRODUCTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 106 CHINA: MEDICAL AESTHETIC PRODUCTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 107 CHINA: MEDICAL AESTHETIC PRODUCTS MARKET, FOR BOTULINUM TOXIN (BOTOX), BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 108 CHINA: MEDICAL AESTHETIC PRODUCTS MARKET, FOR DERMAL FILLERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 109 CHINA: MEDICAL AESTHETIC PRODUCTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 110 CHINA: MEDICAL AESTHETIC PRODUCTS MARKET, BY GENDER, 2019-2032 (USD MILLION)
  • TABLE 111 CHINA: MEDICAL AESTHETIC PRODUCTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 112 INDIA: MEDICAL AESTHETIC PRODUCTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 113 INDIA: MEDICAL AESTHETIC PRODUCTS MARKET, FOR BOTULINUM TOXIN (BOTOX), BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 114 INDIA: MEDICAL AESTHETIC PRODUCTS MARKET, FOR DERMAL FILLERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 115 INDIA: MEDICAL AESTHETIC PRODUCTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 116 INDIA: MEDICAL AESTHETIC PRODUCTS MARKET, BY GENDER, 2019-2032 (USD MILLION)
  • TABLE 117 INDIA: MEDICAL AESTHETIC PRODUCTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 118 JAPAN: MEDICAL AESTHETIC PRODUCTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 119 JAPAN: MEDICAL AESTHETIC PRODUCTS MARKET, FOR BOTULINUM TOXIN (BOTOX), BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 120 JAPAN: MEDICAL AESTHETIC PRODUCTS MARKET, FOR DERMAL FILLERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 121 JAPAN: MEDICAL AESTHETIC PRODUCTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 122 JAPAN: MEDICAL AESTHETIC PRODUCTS MARKET, BY GENDER, 2019-2032 (USD MILLION)
  • TABLE 123 JAPAN: MEDICAL AESTHETIC PRODUCTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 124 SOUTH KOREA: MEDICAL AESTHETIC PRODUCTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 125 SOUTH KOREA: MEDICAL AESTHETIC PRODUCTS MARKET, FOR BOTULINUM TOXIN (BOTOX), BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 126 SOUTH KOREA: MEDICAL AESTHETIC PRODUCTS MARKET, FOR DERMAL FILLERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 127 SOUTH KOREA: MEDICAL AESTHETIC PRODUCTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 128 SOUTH KOREA: MEDICAL AESTHETIC PRODUCTS MARKET, BY GENDER, 2019-2032 (USD MILLION)
  • TABLE 129 SOUTH KOREA: MEDICAL AESTHETIC PRODUCTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 130 AUSTRALIA: MEDICAL AESTHETIC PRODUCTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 131 AUSTRALIA: MEDICAL AESTHETIC PRODUCTS MARKET, FOR BOTULINUM TOXIN (BOTOX), BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 132 AUSTRALIA: MEDICAL AESTHETIC PRODUCTS MARKET, FOR DERMAL FILLERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 133 AUSTRALIA: MEDICAL AESTHETIC PRODUCTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 134 AUSTRALIA: MEDICAL AESTHETIC PRODUCTS MARKET, BY GENDER, 2019-2032 (USD MILLION)
  • TABLE 135 AUSTRALIA: MEDICAL AESTHETIC PRODUCTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 136 NEW ZEALAND: MEDICAL AESTHETIC PRODUCTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 137 NEW ZEALAND: MEDICAL AESTHETIC PRODUCTS MARKET, FOR BOTULINUM TOXIN (BOTOX), BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 138 NEW ZEALAND: MEDICAL AESTHETIC PRODUCTS MARKET, FOR DERMAL FILLERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 139 NEW ZEALAND: MEDICAL AESTHETIC PRODUCTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 140 NEW ZEALAND: MEDICAL AESTHETIC PRODUCTS MARKET, BY GENDER, 2019-2032 (USD MILLION)
  • TABLE 141 NEW ZEALAND: MEDICAL AESTHETIC PRODUCTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 142 REST OF ASIA PACIFIC: MEDICAL AESTHETIC PRODUCTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 143 REST OF ASIA PACIFIC: MEDICAL AESTHETIC PRODUCTS MARKET, FOR BOTULINUM TOXIN (BOTOX), BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 144 REST OF ASIA PACIFIC: MEDICAL AESTHETIC PRODUCTS MARKET, FOR DERMAL FILLERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 145 REST OF ASIA PACIFIC: MEDICAL AESTHETIC PRODUCTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 146 REST OF ASIA PACIFIC: MEDICAL AESTHETIC PRODUCTS MARKET, BY GENDER, 2019-2032 (USD MILLION)
  • TABLE 147 REST OF ASIA PACIFIC: MEDICAL AESTHETIC PRODUCTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 148 REST OF THE WORLD: MEDICAL AESTHETIC PRODUCTS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 149 REST OF THE WORLD: MEDICAL AESTHETIC PRODUCTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 150 REST OF THE WORLD: MEDICAL AESTHETIC PRODUCTS MARKET, FOR BOTULINUM TOXIN (BOTOX), BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 151 REST OF THE WORLD: MEDICAL AESTHETIC PRODUCTS MARKET, FOR DERMAL FILLERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 152 REST OF THE WORLD: MEDICAL AESTHETIC PRODUCTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 153 REST OF THE WORLD: MEDICAL AESTHETIC PRODUCTS MARKET, BY GENDER, 2019-2032 (USD MILLION)
  • TABLE 154 REST OF THE WORLD: MEDICAL AESTHETIC PRODUCTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 155 MIDDLE EAST: MEDICAL AESTHETIC PRODUCTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 156 MIDDLE EAST: MEDICAL AESTHETIC PRODUCTS MARKET, FOR BOTULINUM TOXIN (BOTOX), BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 157 MIDDLE EAST: MEDICAL AESTHETIC PRODUCTS MARKET, FOR DERMAL FILLERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 158 MIDDLE EAST: MEDICAL AESTHETIC PRODUCTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 159 MIDDLE EAST: MEDICAL AESTHETIC PRODUCTS MARKET, BY GENDER, 2019-2032 (USD MILLION)
  • TABLE 160 MIDDLE EAST: MEDICAL AESTHETIC PRODUCTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 161 AFRICA: MEDICAL AESTHETIC PRODUCTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 162 AFRICA: MEDICAL AESTHETIC PRODUCTS MARKET, FOR BOTULINUM TOXIN (BOTOX), BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 163 AFRICA: MEDICAL AESTHETIC PRODUCTS MARKET, FOR DERMAL FILLERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 164 AFRICA: MEDICAL AESTHETIC PRODUCTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 165 AFRICA: MEDICAL AESTHETIC PRODUCTS MARKET, BY GENDER, 2019-2032 (USD MILLION)
  • TABLE 166 AFRICA: MEDICAL AESTHETIC PRODUCTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 167 LATIN AMERICA: MEDICAL AESTHETIC PRODUCTS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 168 LATIN AMERICA: MEDICAL AESTHETIC PRODUCTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 169 LATIN AMERICA: MEDICAL AESTHETIC PRODUCTS MARKET, FOR BOTULINUM TOXIN (BOTOX), BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 170 LATIN AMERICA: MEDICAL AESTHETIC PRODUCTS MARKET, FOR DERMAL FILLERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 171 LATIN AMERICA: MEDICAL AESTHETIC PRODUCTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 172 LATIN AMERICA: MEDICAL AESTHETIC PRODUCTS MARKET, BY GENDER, 2019-2032 (USD MILLION)
  • TABLE 173 LATIN AMERICA: MEDICAL AESTHETIC PRODUCTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 174 ARGENTINA: MEDICAL AESTHETIC PRODUCTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 175 ARGENTINA: MEDICAL AESTHETIC PRODUCTS MARKET, FOR BOTULINUM TOXIN (BOTOX), BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 176 ARGENTINA: MEDICAL AESTHETIC PRODUCTS MARKET, FOR DERMAL FILLERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 177 ARGENTINA: MEDICAL AESTHETIC PRODUCTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 178 ARGENTINA: MEDICAL AESTHETIC PRODUCTS MARKET, BY GENDER, 2019-2032 (USD MILLION)
  • TABLE 179 ARGENTINA: MEDICAL AESTHETIC PRODUCTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 180 BRAZIL: MEDICAL AESTHETIC PRODUCTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 181 BRAZIL: MEDICAL AESTHETIC PRODUCTS MARKET, FOR BOTULINUM TOXIN (BOTOX), BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 182 BRAZIL: MEDICAL AESTHETIC PRODUCTS MARKET, FOR DERMAL FILLERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 183 BRAZIL: MEDICAL AESTHETIC PRODUCTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 184 BRAZIL: MEDICAL AESTHETIC PRODUCTS MARKET, BY GENDER, 2019-2032 (USD MILLION)
  • TABLE 185 BRAZIL: MEDICAL AESTHETIC PRODUCTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 186 COLOMBIA: MEDICAL AESTHETIC PRODUCTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 187 COLOMBIA: MEDICAL AESTHETIC PRODUCTS MARKET, FOR BOTULINUM TOXIN (BOTOX), BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 188 COLOMBIA: MEDICAL AESTHETIC PRODUCTS MARKET, FOR DERMAL FILLERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 189 COLOMBIA: MEDICAL AESTHETIC PRODUCTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 190 COLOMBIA: MEDICAL AESTHETIC PRODUCTS MARKET, BY GENDER, 2019-2032 (USD MILLION)
  • TABLE 191 COLOMBIA: MEDICAL AESTHETIC PRODUCTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 192 REST OF LATIN AMERICA: MEDICAL AESTHETIC PRODUCTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 193 REST OF LATIN AMERICA: MEDICAL AESTHETIC PRODUCTS MARKET, FOR BOTULINUM TOXIN (BOTOX), BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 194 REST OF LATIN AMERICA: MEDICAL AESTHETIC PRODUCTS MARKET, FOR DERMAL FILLERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 195 REST OF LATIN AMERICA: MEDICAL AESTHETIC PRODUCTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 196 REST OF LATIN AMERICA: MEDICAL AESTHETIC PRODUCTS MARKET, BY GENDER, 2019-2032 (USD MILLION)
  • TABLE 197 REST OF LATIN AMERICA: MEDICAL AESTHETIC PRODUCTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 198 PRODUCT LAUNCH
  • TABLE 199 PRODUCT APPROVAL
  • TABLE 200 AGREEMENT
  • TABLE 201 EXPANSION
  • TABLE 202 REVANCE THERAPEUTICS: PRODUCTS OFFERED
  • TABLE 203 REVANCE THERAPEUTICS: KEY DEVELOPMENTS
  • TABLE 204 ABBVIE, INC.: PRODUCTS OFFERED
  • TABLE 205 ABBVIE, INC.: KEY DEVELOPMENTS
  • TABLE 206 SUNEVA MEDICAL: PRODUCTS OFFERED
  • TABLE 207 SUNEVA MEDICAL: KEY DEVELOPMENTS
  • TABLE 208 BIOXIS PHARMACEUTICALS: PRODUCTS OFFERED
  • TABLE 209 MERZ PHARMA: PRODUCTS OFFERED
  • TABLE 210 MERZ PHARMA: KEY DEVELOPMENTS
  • TABLE 211 GALDERMA: PRODUCTS OFFERED
  • TABLE 212 SINCLAIR: PRODUCTS OFFERED
  • TABLE 213 SINCLAIR: KEY DEVELOPMENTS
  • TABLE 214 MEDYTOX: PRODUCT OFFERED
  • TABLE 215 TEOXANE: PRODUCTS OFFERED
  • TABLE 216 TEOXANE: KEY DEVELOPMENTS
  • TABLE 217 DR.KORMAN: PRODUCTS OFFERED

LIST OF FIGURES

  • FIGURE 1 MEDICAL AESTHETIC PRODUCTS MARKET: STRUCTURE
  • FIGURE 2 MEDICAL AESTHETIC PRODUCTS MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032)
  • FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
  • FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032)
  • FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: MEDICAL AESTHETIC PRODUCTS MARKET
  • FIGURE 6 MEDICAL AESTHETIC PRODUCTS MARKET, PRODUCT SEGMENT, 2023 &
  • FIGURE 7 MEDICAL AESTHETIC PRODUCTS MARKET, BY PRODUCT, 2023 & 2032 (USD MILLION)
  • FIGURE 8 MEDICAL AESTHETIC PRODUCTS MARKET SHARE (%), BY PRODUCT,
  • FIGURE 9 MEDICAL AESTHETIC PRODUCTS MARKET, APPLICATION SEGMENT, 2023 &
  • FIGURE 10 MEDICAL AESTHETIC PRODUCTS MARKET, BY APPLICATION, 2023 & 2032 (USD MILLION)
  • FIGURE 11 MEDICAL AESTHETIC PRODUCTS MARKET SHARE (%), BY APPLICATION,
  • FIGURE 12 MEDICAL AESTHETIC PRODUCTS MARKET, GENDER SEGMENT, 2023 &
  • FIGURE 13 MEDICAL AESTHETIC PRODUCTS MARKET, BY GENDER, 2023 & 2032 (USD MILLION)
  • FIGURE 14 MEDICAL AESTHETIC PRODUCTS MARKET SHARE (%), BY GENDER,
  • FIGURE 15 MEDICAL AESTHETIC PRODUCTS MARKET, END USER SEGMENT, 2023 &
  • FIGURE 16 MEDICAL AESTHETIC PRODUCTS MARKET, BY END USER, 2023 & 2032 (USD MILLION)
  • FIGURE 17 MEDICAL AESTHETIC PRODUCTS MARKET SHARE (%), BY GENDER,
  • FIGURE 18 MEDICAL AESTHETIC PRODUCTS MARKET, BY REGION, 2023 & 2032 (USD MILLION)
  • FIGURE 19 MEDICAL AESTHETIC PRODUCTS MARKET SHARE (%), BY REGION,
  • FIGURE 20 NORTH AMERICA MARKET ANALYSIS: MEDICAL AESTHETIC PRODUCTS MARKET, 2019-2032 (USD MILLION)
  • FIGURE 21 NORTH AMERICA MEDICAL AESTHETIC PRODUCTS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 22 NORTH AMERICA MEDICAL AESTHETIC PRODUCTS MARKET SHARE (%), BY COUNTRY,
  • FIGURE 23 EUROPE MARKET ANALYSIS: MEDICAL AESTHETIC PRODUCTS MARKET, 2019-2032 (USD MILLION)
  • FIGURE 24 EUROPE MEDICAL AESTHETIC PRODUCTS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 25 EUROPE MEDICAL AESTHETIC PRODUCTS MARKET SHARE (%), BY COUNTRY,
  • FIGURE 26 ASIA PACIFIC MARKET ANALYSIS: MEDICAL AESTHETIC PRODUCTS MARKET, 2019-2032 (USD MILLION)
  • FIGURE 27 ASIA PACIFIC: MEDICAL AESTHETIC PRODUCTS MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 28 ASIA PACIFIC: MEDICAL AESTHETIC PRODUCTS MARKET SHARE, BY COUNTRY, 2023 (%)
  • FIGURE 29 REST OF THE WORLD MARKET ANALYSIS: MEDICAL AESTHETIC PRODUCTS MARKET, 2019-2032 (USD MILLION)
  • FIGURE 30 REST OF THE WORLD: MEDICAL AESTHETIC PRODUCTS MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 31 REST OF THE WORLD: MEDICAL AESTHETIC PRODUCTS MARKET SHARE, BY COUNTRY, 2023 (%)
  • FIGURE 32 MEDICAL AESTHETIC PRODUCTS MARKET PLAYERS: COMPETITIVE ANALYSIS,
  • FIGURE 33 MEDICAL AESTHETIC PRODUCTS MARKET PLAYERS: COMPETITIVE ANALYSIS,
  • FIGURE 34 COMPETITOR DASHBOARD: MEDICAL AESTHETIC PRODUCTS MARKET
  • FIGURE 35 REVANCE THERAPEUTICS: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 36 REVANCE THERAPEUTICS: SWOT ANALYSIS
  • FIGURE 37 ABBVIE, INC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 38 ABBVIE, INC.: SWOT ANALYSIS
  • FIGURE 39 SUNEVA MEDICAL: SWOT ANALYSIS
  • FIGURE 40 GALDERMA: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 41 GALDERMA: SWOT ANALYSIS
  • FIGURE 42 SINCLAIR: SWOT ANALYSIS